RARE vs UGI · rev $560.2M vs P/E 12, rev $7.29B
Ultragenyx (RARE) versus UGI Corporation (UGI) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
UGI Corporation (UGI) is a utilities - regulated gas company listed on NYSE.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported UGI revenue for 2025-09-30 was $7.29B. Net income was $678.0M. Revenue was up 1.1% from 2024-09-30 to 2025-09-30. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
RARE currently screens at market cap $2.79B. UGI currently screens at market cap $7.21B and trailing P/E 11.8.
Not investment advice. Open the RARE and UGI stock pages for the full models.
Not investment advice.